Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer.
Journal of Thoracic Oncology.
Times cited: 75
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.
Times cited: 389